Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.

CONCLUSIONS: Nabilone pharmacotherapy was safe and well-tolerated in participants with cannabis dependence. Future studies might evaluate a higher dose of nabilone to determine its effects on cannabis use outcomes in participants with cannabis dependence.
SCIENTIFIC SIGNIFICANCE: There remains a clear need for additional pharmacotherapy trials for cannabis dependence, and nabilone remains a candidate for such trials. (Am J Addict 2017;XX:1-7).
PMID: 28921814 [PubMed - as supplied by publisher]

Source: American Journal on Addictions - September 18, 2017 Category: Addiction Authors: Hill KP, Palastro MD, Gruber SA, Fitzmaurice GM, Greenfield SF, Lukas SE, Weiss RD Tags: Am J Addict Source Type: research